TREMFYA 100 MG / 1 ML
GUSELKUMAB : 100 MG / 1 ML · DIN 02469758 · JANSSEN INC
Health Canada status: MARKETED
What is TREMFYA?
TREMFYA 100 MG / 1 ML contains GUSELKUMAB : 100 MG / 1 ML. It is listed in the Health Canada Drug Product Database under DIN 02469758, held by JANSSEN INC, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 27-Nov-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TREMFYA used for?
TREMFYA® is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and for the treatment of adult patients with active psoriatic arthritis. TREMFYA® / TREMFYA® I.V. is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease and ulcerative colitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02469758 |
|---|---|
| Brand name | TREMFYA |
| Generic / active ingredient | GUSELKUMAB : 100 MG / 1 ML |
| Manufacturer | JANSSEN INC |
| Strength | 100 MG / 1 ML |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Schedule D |
| ATC code | L04AC16 GUSELKUMAB |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Nov-2017 |
How is it stored and handled?
Before injection, remove TREMFYA ® from the refrigerator and allow TREMFYA ® to reach room temperature (30 minutes) without removing from the carton.
How is it supplied?
Solution for injection: 100 mg/1 mL Pre-filled syringe, 200 mg/2 mL Pre-filled syringe, 200 mg/2 mL Pre-filled pen. Patient-controlled injector: 100 mg/1 mL. Solution for intravenous infusion: 200 mg/20 mL vial.
What can be used instead?
Other Canadian products sharing ATC code L04AC16 GUSELKUMAB. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TREMFYA | 200 MG / 2 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02559145 |
| TREMFYA I.V. | 200 MG / 20 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02559153 |
| TREMFYA ONE-PRESS | 100 MG / 1 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02487314 |
| TREMFYA | 200 MG / 2 ML | SOLUTION | JANSSEN INC | APPROVED | DIN 02559137 |
Who else supplies GUSELKUMAB worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GUSELKUMAB appears in 43 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.